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Prometryne is a methylthio-s-triazine herbicide. Signifi cant trace amounts are found in the environment, 
mainly in water, soil, and food plants. The aim of this study was to establish brain and blood prometryne 
levels after single oral dose (1 g kg-1) in adult male and female mice. Prometryne was measured using the 
GC/MS assay at 1, 2, 4, 8, and 24 h after prometryne administration. Peak brain and blood prometryne 
values were observed 1 h after administration and they decreased in a time-dependent manner. Male mice 
had consistently higher brain and blood prometryne levels than female mice. The observed prometryne 
kinetics was similar to that reported for the structurally related herbicide atrazine.
KEY WORDS: blood, herbicide, nervous system, toxicity, triazine
Đikić D, et al. BRAIN TOXICOKINETICS OF PROMETRYNE IN MICE
Arh Hig Rada Toksikol 2010;61:19-27
Prometryne (N,N’-bis(1-methylethyl)-6-
(methylthio)-1,3,5-triazine-2,4-diamine) is used to 
control annual broadleaf and grass weeds in corn, 
carrots, parsley, peanuts, cotton, pigeon peas, alfalfa, 
and many other cultivated plants (1-4). Its use has been 
associated with increased levels in soil, water, and air, 
and a risk to the environment and human health (5). 
Prometryne is relatively persistent in water (6-8) and 
soil (9, 10). It can also be found in ambient air near 
production or application sites (11). Signifi cant traces 
were documented in plants consumed by humans 
and domestic animals (9, 12-14) and medicinal 
plants treated with this herbicide (15). Trace levels 
of prometryne have also been reported in cow and 
human milk (16, 17). Only minimal information on 
the toxicokinetics of triazine herbicides in mammals 
has been published and the knowledge about 
prometryne kinetics in various organs is restricted 
to rats (18, 19). Little is known about prometryne 
presence in the central nervous system (CNS), but the 
partition coeffi cient log K
ow
=3.5 (2) and the polarity 
of prometryne suggest that it might enter the CNS. 
The objective of this study was to see the kinetics 
of a single oral dose (1 g kg-1) of prometryne in the 
brain and blood of CBA mice and to compare it with 
previously reported kinetics of the structurally related 
and widely used herbicide atrazine. We also wanted 




For the experiment we used inbred CBA mice of 
both sexes [(65±3) days old; male=(23.37±1.99) g; 
female=(22.25±1.14) g] from a mouse colony of the 
Zagreb University Faculty of Science. The animals 
were fed on a pellet diet (Pliva, Zagreb, Croatia) and 
had free access to tap water. Light and dark exchanged 
20
every 12 hours. The experiment observed the Croatian 
animal welfare regulations (20) and the Guide for the 
Care and Use of Laboratory Animals (21).
Treatment of experimental animals with prometryne
The mice were randomly distributed to five 
experimental groups of 12 animals each, six male 







S; CAS No. 7287-19-6, EPA Reg. No. 9779-
297; technical grade 95 %; Herbos, Sisak, Croatia) 
oral dose of 1 g kg-1 body mass in a 0.2 mL corn oil 
suspension. The control group was randomly selected 
from among sibling littermates and treated with the 
same volume of corn oil without prometryne. The 
control group also served to verify that the animals 
had not been exposed to prometryne through food or 
water.
The selected prometryne dose was the closest to 
the 1/3 of mice LD
50
 of 3.75 g kg-1 that did not show 
lethal toxicity (LD
10
) over 48 consecutive hours after 
administration, as established by pilot tests reported 
by EPA (1). Dosing was based previous toxicokinetic 
studies (22-26) that used doses higher than normally 
environmentally available to ensure detectable residue 
levels for our purposes.
Mice were weighed before oral administration of 
prometryne. Corn oil suspension with prometryne was 
given in the volume of 0.2 mL per animal with small 
adjustments to individual body mass to keep the same 
dose of prometryne per kilogram of body mass.
The mice were monitored for any visible clinical 
or behavioural signs of poisoning. They were killed 
by cervical dislocation one, two, four, eight, and 24 
hours after prometryne administration.
The whole experiment was repeated three times.
Collection of blood and brains
Blood was collected from the heart according to 
the standard protocol (27). Samples of whole blood 
were immediately frozen (-80 °C) until further use, 
which followed within three days.
After blood collection, animals were perfused 
with PBS to make sure that the brain prometryne 
referred to brain parenchyma only. Dissected brains 
were placed on ice pads, weighed and immediately 
homogenised with constant cooling. To collect brain 
and blood samples we used new and thoroughly 
cleaned sets of instruments for each mouse to avoid 
any contamination with traces of prometryne from 
other animals.
Brain and blood prometryne extraction and the 
GC/MS assay
Blood and brain prometryne was analysed using the 
standard GC/MS assay as described earlier (22, 28). 
Briefl y, to extract prometryne from blood and brain, we 
mixed 0.2 mL of water atrazine solution (3.5 μg mL
-1
) 





, Kemika, Zagreb, Croatia) with 0.5 mL of 
homogenised sample. After the salt was diluted, we 
added 2 mL of ethyl acetate/dichloromethane mixture 
(1:3; Sigma-Aldrich, Taufkirchen, Germany). After 
5 min of vortexing and 10 min of centrifugation 
(6000 rpm), 1 mL of supernatant was transferred and 
desiccated. After desiccation, 0.1 mL of n-hexane 
(Sigma-Aldrich) was added to the sample for injection 
into a chromatograph Shimadzu GCMS-QP2010S with 
a5970 MSD model. We used a HP-5ms GC column 
(30 m, 0.25 mm i.d.; J&W Agilent Technologies, 
USA). The injection temperature was 275 °C , with 
an oven temperature of 90 °C increased to 280 °C 
in 11 min. A blank sample of blood and brains from 
control animals was measured in parallel to make sure 
that the animals were not exposed to prometryne or 
atrazine (used as an internal standard) through food 
or water. To establish the calibration curve, we used 
20 known concentrations of prometryne and atrazine 
(range: 4 ng mL-1 to 2000 ng mL-1) which were added 
to the brain and blood samples collected from control 
mice. Each time before measurement, we added 
0.2 mL of internal standard for every 0.5 mL of real 
samples from animals that received prometryne, and 
recovery was 80 % to 85 %. No traces of metabolites 
were seen.
Statistical analysis
For statistical analyses we used Statistica 5.0 
software (StatSoft, Tulsa, USA). We analysed group 
means (± standard deviation of the mean) and made 
multiple comparisons between groups and sexes with 
ANOVA. For post-hoc analysis of differences between 
groups we employed Scheffé’s and Duncan’s test. 
We also determined the correlation and regression 
coeffi cients between brain and blood concentrations. 
The level of statistical signifi cance was set at P≤0.01 
and P≤0.05.
RESULTS
Tables 1 and 2 show blood and brain prometryne 
contents, respectively. The fi rst two rows in both tables 
Đikić D, et al. BRAIN TOXICOKINETICS OF PROMETRYNE IN MICE
Arh Hig Rada Toksikol 2010;61:19-27
21




Blood prometryne concentration / ng mL-1
Mean S.D. Median Min. Max.
m 2765.22 a 671.83 2911.83 1811.67 3486.67
1 h f 1740.50 789.18 1484.00 1077.67 3246.33
m+f 2252.86A 880.13 1990.50 1077.67 3486.67
m 1144.74 327.25 1172.96 645.81 1516.88
2 h f 779.72 436.16 675.31 384.55 1624.33
m+f 962.23B 414.11 850.46 384.55 1624.33
m 622.43a 179.86 663.85 281.35 799.24
4 h f 403.96 179.54 363.83 200.81 737.73
m+f 513.19C 205.85 519.36 200.81 799.24
m 151.41a 53.97 152.46 59.27 216.53
8 h f 83.40 33.84 73.67 42.66 142.99
m+f 117.41D 55.73 116.66 42.66 216.53
m 31.54a 12.24 30.26 14.41 51.78
24 h f 17.91 6.54 16.55 11.57 30.19
m+f 24.73E 11.76 22.95 11.57 51.78
A-E A>B>C>D>E at a signifi cant level (P≤0.01)
a signifi cantly higher (P≤0.05) than in female mice at the same time point
Table 2 Brain prometryne mass fraction in mice at different time points after administration of a single oral dose (1 g kg-1)
Sampling time Sex
Brain prometryne mass fraction / ng mg-1
Mean S.D. Median Min. Max.
m 9.502a 2.123 9.767 6.751 12.416
1 h f 6.256 2.687 5.115 3.890 9.887
m+f 7.879A 2.864 8.384 3.890 12.416
m 2.560 0.728 2.384 1.857 3.975
2 h f 2.006 0.881 1.708 1.279 3.656
m+f 2.283B 0.823 2.254 1.279 3.975
m 1.188 0.268 1.142 0.882 1.577
4 h f 1.015 0.391 0.826 0.653 1.577
m+f 1.102C 0.332 1.045 0.653 1.577
m 0.441 0.166 0.394 0.276 0.667
8 h f 0.338 0.091 0.328 0.236 0.448
m+f 0.389D 0.139 0.346 0.236 0.620
m 0.102 0.031 0.101 0.051 0.138
24 h f 0.090 0.024 0.085 0.065 0.133
m+f 0.096E 0.027 0.094 0.065 0.138
A-E A>B>C>D>E at a signifi cant level (P≤0.01)
a signifi cantly higher (P≤0.05) than in female mice at the same time point a signifi cantly increased (p ≤ 0.05) compared to the 
value recorded in female mice at the same time point
bring separate results by the sexes and the third row 
combines these results. Table 3 is structured like the 
fi rst two tables and shows correlation and regression 
coefficients. Figures 1 and 2 show brain-blood 
correlations in either sex, and Figure 3 combines 
them.
Blood prometryne concentration
Prometryne (in ng mL-1) was detected in all blood 
samples collected over 24 hours from administration 
(Table 1). During that time blood concentration 
declined steadily. One hour after dosing, blood 
prometryne signifi cantly differed (P≤0.01) between 
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male and female mice, as males had almost double 
(1.6 fold) the prometryne concentration in females. 
Two hours after prometryne administration, females 
had 1.5 times lower blood prometryne than males, but 
the difference was not signifi cant. Viewed combined 
(m+f), prometryne concentration dropped 2.3 times 
from hour one to hour two post dosing (P≤0.01).
Four hours after administration, blood prometryne 
dropped further still (1.9 times in respect to hour two, 
P≤0.01 and 4.4 times in respect to hour one, P≤0.01). 
Again, the difference between males and females 
was significant (1.5 times lower in female mice, 
P≤0.01). On hours eight and 24 blood prometryne 
rapidly dropped in all treated animals; it dropped 
4.4 times between hour four and eight and 4.7 times 
between hours 8 and 24. The difference between the 
sexes was still signifi cant (P≤0.01, 1.8 times lower in 
female mice).
Prometryne in brain
Prometryne (in ng mg-1) was detected in the brains 
of mice at all time points over the 24 hours after 
administration (Table 2). Brain prometryne mass 
fractions steadily declined throughout the experiment. 
On post-dose hour one, it was 1.5 times higher in male 
than in female mice (P≤0.01), which is similar to blood 
concentration differences between the sexes. On hour 
two post dose (m+f), the mass fraction dropped 3.5 
times (P≤0.01). Female mice now had 1.3 times lower 
prometryne brain mass fraction than male mice, but 
the difference was not signifi cant. Again even though 
female mice had 1.3 times lower brain prometryne, the 
Figure 1  The relationship between brain and blood prometryne levels measured at different time points after administration 
of a single dose in male CBA mice
Figure 2  The relationship between brain and blood prometryne levels of prometryne measured at different time points after 
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difference was not statistically signifi cant. On hours 
eight
 
and 24, brain prometryne was very low, but still 
detectable. It dropped 2.8 times from hour four to eight 
and 4.05 times from hour eight to 24. Female mice 
had 1.1 times lower brain prometryne than male mice 
on hour eight and 1.5 times on hour 24 post dose, but 
again, the difference was not statistically signifi cant.
Correlation and regression analysis
Table 3 and Figures 1-3 show the correlation 
between blood and brain prometryne levels and 
regression coeffi cients. The highest signifi cant positive 
correlation between brain and blood prometryne 
was determined in samples analysed one hour after 
administration. Two hours after administration, the 
correlation was still signifi cant and positive in females, 
but not in males. When analysed together, however, 
the correlation was positive and almost signifi cant 
(P=0.0508). The same was observed for samples 
collected four hours post dose. Again, the correlation 
was positive in both sexes, but signifi cant (P≤0.05) 
only in female mice. The correlation for combined data 
was positive and signifi cant (P≤0.05), although lower 
than on hour two. On hours eight and 24
 
post dose the 
correlation between brain and blood prometryne levels 
was no longer signifi cant in any group.
DISCUSSION
This study was designed to simulate a normal oral 
exposure to prometryne from the environment (29) as 
previously shown by Maynard et al. (22) in rats. One 
of the goals was to compare the allometric differences 
(30-32) between rats used in the study of Maynard et 
al. (22) and mice which we regularly used in earlier 
prometryne toxicity studies (33, 34). One of the key 
documents that directed the experiment was the OECD 
407 guideline for 28-day subchronic toxicity studies 
in rodents (21). According to this guideline, it is safe 
to give tested chemicals at intervals of every 24 h 
to avoid overdosing or bioaccumulation. However, 
Maynard et al. (22) established prometryne presence 
in rats even after 48 h. While no such fi ndings have 
been available for mice our results suggest that even 
though OECD 407 guideline recommends 24-h 
intervals for test chemicals, this recommendation 
should be taken with caution. After 24 h, prometryne 
was not completely eliminated from the blood of 
mice (Table 1), which suggests that the remaining 
prometryne concentrations, however low, might build 
up with subchronic dosing and raise the bioavailable 
concentration (29).
Although prometryne was present in the blood 
of exposed animals, its percentage in respect to the 
Table 3  Correlation and regression coeffi cients between brain and blood prometryne level at different sampling times following 
a single oral dose (1 g kg-1)
Sampling time Sex  r  b  R2 Signifi cance
m 0.87707 0.00280 0.76930 P≤0.01
1 h f 0.83252 0.00280 0.69310 P≤0.01
m+f 0.90510 0.00294 0.81940 P≤0.01
m 0.33125 0.00070 0.10970
2 h f 0.93988 0.00190 0.88340 P≤0.01
m+f 0.74860 0.00149 0.56050 P≤0.05
m 0.39374 0.00060 0.15500
4 h f 0.73704 0.00160 0.54320 P≤0.05
m+f 0.61870 0.00098 0.38230
m 0.20636 0.00060 0.04260
8 h f 0.36176 0.00100 0.13090
m+f 0.42400 0.00105 0.18000
m -0.87960 -0.00220 0.77370 P≤0.01
24 h f 0.68227 0.00250 0.46550
m+f -0.24070 -0.00054 0.57900
r – correlation coeffi cient
b, R2 – regression coeffi cients
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administered dose was relatively low. Maynard et al. 
(22) found that 1.2 % to 1.9 % of the original oral dose 
of prometryne was absorbed and distributed in the 
blood of rats. All this suggests that blood absorption 
of orally administered prometryne is relatively low, 
at least in laboratory rodents.
Data about prometryne toxicokinetics in the 
CNS of mammals are scarce, and our study gives an 
elementary view of prometryne’s potential fraction and 
retention in the brain of mice (Table 2). Prometryne 
in mice brain was in even lower levels than in blood 
(Table 2). We selected the brain as the study organ 
for prometryne toxicokinetics (35) because it is well 
protected against xenobiotics and the hardest of organs 
to penetrate (36-38).
Prometryne’s unpolar molecular structure and its 
octanol/water partition coeffi cient make prometryne 
likely to reach the brain, because brain structures 
are rich in lipids and have a tendency to uptake or 
concentrate lipofi lic substances (37, 39). Having in 
mind that prometryne has low blood absorption and 
yet it has been traced in so distant a compartment as 
the brain over 24 h, then this means that prometryne 
has a potential to pass through all compartments of 
the mammalian organism, including placenta and put 
embryo at risk.
To the best of our knowledge, our study is the 
fi rst to show the potential of prometryne to enter 
mouse brain, and it is the fi rst to analyse prometryne 
absorption, bioaccumulation, and elimination in neural 
tissue over a short time. The only records available in 
literature refer to the neurotoxic kinetics of atrazine, 
a pesticide structurally similar to prometryne (23, 
24, 26). Due to similar structure, the two compounds 
may share some toxicological properties (33, 34). Our 
results confi rm this assumption, as they correspond to 
the fi ndings of Stoker and Cooper (40), who examined 
the toxicokinetics of atrazine in rat brain and other 
organs. Similar to our results for prometryne, about 
0.003 % of the administered dose of atrazine was 
found in the brain (40).
Atrazine seems to directly affect the neuroendrocrine 
function (40, 41). As our results confi rm the affi nity 
of prometryne for neural tissue, similar effects on the 
neuroendocrine functions are possible, but they have 
to be verifi ed in future studies.
Brain and blood prometryne levels in our study 
decreased over 24
 
h (Tables 1, 2, and 3) and correlated 
well, but not over the full range of data. This fi nding 
is expected, given the rapid distribution and/or 
elimination in the fi rst two hours. Slower elimination 
is expected from hours 2 to 8, with elimination half-
time (t
1/2
) of approximately 2 h, and even slower 
terminal elimination with a half life of about 8 h. 
Similar decline was demonstrated for atrazine in rats 
(23). It could be concluded that most of prometryne 
absorption in mouse blood occurs within the fi rst hour, 
followed by a rapid decline in concentration. This drop 
in the prometryne level is highly correlated between 
the brain and blood (Table 3 and Figure 1). The 
decrease rate from hour one to hour two is higher in the 
brain (Δc
m+f
=3.45x h-1) than in blood (Δc
m+f
=2.34x h-1). 
This points to an active process of rapid prometryne 
elimination from the brain, since the prometryne has 
to move from brain against the higher concentration 
in blood (36, 44, 45).
Figure 3  The relationship between brain and blood levels of prometryne measured at different time points after administration 
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In our study, we also observed sex-related 
differences in brain and blood prometryne kinetics. 
Blood prometryne was signifi cantly higher in male 
than in female mice at all measured times, save for hour 
two when it was higher, but not signifi cantly. Brain 
prometryne levels were similar between males and 
females, except on hour one measurement when males 
had a signifi cantly higher prometryne mass fraction. 
The differences between the sexes are particularly 
clear if one looks at medians (Tables 1 and 2). Higher 
prometryne levels (especially the peak values of the 
hour one) in males suggest higher absorption than 
in females. We also observed a different dynamic of 
change between the sexes. In both brain and blood, 
males had 1.5 times higher values on hour one. In 
the brain this difference was dropping towards hour 
24 (1.1 times), while in blood it rose (1.76 times 
on hour 24). This might be explained by different 
body mass between the sexes [male=(23.37±1.99) g; 
female=(22.25±1.14) g] or by different fat and muscle 
ratio. Another explanation might be that active brain 
elimination occurs at the same rate regardless of the 
sex, while elimination mechanisms (detoxifi cation 
enzymes) in blood may slightly differ between 
males and females (see the correlation curves in 
Figures 2 and 3). Therefore, neurotoxicity studies of 
prometryne with mice as a model organism should 
take into account sex differences in prometryne brain 
bioavailability.
Log-normal plots reveal a possible three-step 
elimination that could be modelled with classical 
pharmacokinetic models, which could greatly help 
researchers in designing prometryne neurotoxicity 
experiments. In our study, the correlation between 
brain and blood prometryne was stronger in female 
mice. Regression coeffi cients show slower prometryne 
elimination rate in male mice than in female. 
Regression analysis (as in Figures 1, 2, and 3) makes 
it possible to calculate time-course changes in blood 
and brain prometryne levels.
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Sažetak
TOKSIKOKINETIKA PROMETRINA U MOZGU MIŠEVA
Prometrin je metiltio-s-triazinski herbicid. Značajne količine prometrina zaostaju u tragovima u okolišu, 
poglavito u vodi, tlu i biljkama koje rabimo za prehranu. Cilj je rada izmjeriti količinu prometrina koja se 
apsorbira u mozgu i krvi nakon primijenjene akutne oralne doze (1 g kg-1 tjelesne mase) u odraslih miševa 
obaju spolova. Razine prometrina u mozgu i krvi izmjerene su GC/MS-om tijekom 1., 2., 4., 8. i 24. sata 
nakon izlaganja. Utvrđeno je da je udio prometrina koji se zadržava u živčanom tkivu relativno nizak ali 
detektabilan u odnosu na koncentraciju u krvi i koncentraciju primijenjene doze. Najviše koncentracije 
u krvi i maseni udjeli u mozgu zabilježeni su tijekom 1. sata nakon izlaganja, a s vremenom izmjerene 
vrijednosti značajno opadaju. Uočena je značajna razlika između mužjaka i ženki pri čemu mužjaci imaju 
značajno više razine prometrina u mozgu i krvi nego ženke. Opisana toksikokinetika prometrina pokazuje 
sličnosti s otprije opisanom i poznatom toksikokinetikom strukturalno sličnog herbicida atrazina.
KLJUČNE RIJEČI: herbicidi, krv, otrovnost, triazini, živčani sustav
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